Personal

Ticket to Biotech

No refunds will be administered. Be sure that you're an accepted T2B member before paying for your ticket.

***If you do not receive your event confirmation within 1 business day of RSVPing (above), check your email spam folder. The automated Luma email includes the Zoom info and cal invite.***

If you're not part of Ticket to Biotech, 

, and join before registering for this event:

COMM CONVO: BEYOND THE BINDER IN THE ERA OF CONSTANT CRISIS

Crisis readiness carries new weight as political volatility, regulatory shifts, and the speed of social media compress the time between incidents. We're the ones building plans, briefing leadership, and making real-time calls when the traditional scenario-planning binder doesn't match the moment. Traditional crisis plans assume a beginning and an end, though today's environment rarely offers either. This Comm Convo opens a candid conversation about readiness in an age of constant crisis, from real-time decision-making to sustaining teams when there is no recovery period between incidents.

Stephen Majors, VP, Global Communications and Investor Relations, Alliance for Regenerative Medicine

’s 15-year career converged at ARM in his role of Vice President of Communications: A journalist covering politics and state legislatures; a business development professional advising companies on how to navigate geopolitical risk; a pharma and biotech industry consultant; a graduate of journalism and public policy programs.

At ARM, Stephen serves as global media spokesperson and social media strategist and contributes to ARM’s policy and advocacy objectives in Washington, state capitals, and Brussels. He breaks down complex science for the public and policymakers and explains why policies need to change to ensure that patients can benefit from the groundbreaking advancements of ARM’s members.

Stephen thought he left science behind after muddling his way through AP Chemistry in high school. He’s glad he was wrong.

Adam Silverstein, Managing Director, Narrative Strategies

 is a Managing Director in Narrative’s New York office. In this role, Adam counsels a wide range of clients across the healthcare sector, with a focus on pharmaceutical and biotechnology companies.

Adam brings nearly two decades of agency experience in healthcare communications, public relations, and thought leadership. He joins Narrative from Scient Public Relations, where he served as Head of Media Relations & Thought Leadership, advising C-suite leaders and corporate affairs teams on corporate reputation, media strategy, and complex scientific communications. Earlier in his career, Adam held roles of increasing seniority at Edelman and Fleishman Hillard, advising pharmaceutical and biotechnology companies ranging from startups to Fortune 500 organizations.

His work spans companies’ most critical moments, including clinical data, regulatory milestones, executive transitions, and sensitive corporate issues. Over the course of his career, Adam has helped executives build lasting relationships with the journalists covering their companies and industries. He operates as a trusted, embedded partner to executive and R&D leadership teams, as well as the reporters who cover their organizations. He takes a modern approach to media relations that incorporates AI/LLMs into message development and measurement, media strategy, and executive communications.

Adam is a lifelong, mostly hopeless fan of the New York Mets. He lives in New Jersey with his wife, daughter, and son. Adam earned his B.A. from the University of Delaware.

T2B September Comm Convo: Beyond the Binder in the Era of Constant Crisis